Metamizol Kalceks

Metamizole sodium, the active ingredient in Metamizol Kalceks, is a non‑opioid analgesic (pyrazolone) presented as an injectable solution for intramuscular or intravenous use. It is employed to relieve moderate to severe pain and to reduce high fever in adult patients.

GNH USA supplies Metamizol Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for this essential analgesic. Ensuring consistent availability across diverse markets.

Metamizole sodium is used for conditions involving pain and fever, acting as a potent non‑opioid analgesic and antipyretic.

- Pain: provides rapid analgesic relief in acute and postoperative settings - Fever: lowers elevated body temperature in high‑grade febrile states - Post‑operative pain: helps control pain after surgical procedures

Metamizole sodium may be associated with a range of adverse reactions, varying from mild to potentially life‑threatening.

Common Side Effects: - Injection site pain - Nausea - Vomiting - Dizziness

Serious or Rare Side Effects: - Agranulocytosis - Severe skin reactions (Stevens‑Johnson syndrome) - Anaphylactic shock

Metamizole Kalceks should be used with caution in several clinical situations.

- Renal impairment: monitor kidney function and adjust use - Hepatic disease: use with caution and observe liver enzymes - History of blood disorders: avoid or conduct regular blood counts - Concomitant use with other myelosuppressive drugs: increase risk of agranulocytosis - Pregnancy and lactation: only if benefits outweigh risks - Store at ambient temperature: keep in original container, protect from moisture and light

Metamizole sodium can interact with several medication classes.

Major Interactions (Avoid): - Concurrent use with other pyrazolones: heightened risk of severe blood dyscrasias - Combination with ACE inhibitors: may potentiate hypotensive effects - Co‑administration with other NSAIDs: increased renal toxicity

Moderate Interactions (Monitor Closely): - Use with anticoagulants: monitor bleeding parameters - Interaction with lithium: monitor serum lithium levels - Co‑administration with diuretics: watch electrolyte balance